Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$278,033
-$27,092 QoQ
Shares Held
2,988
-13.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#177
of 282 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. BNTX ranks #60 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in BNTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $278,033 | 2,988 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $305,125 | 3,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $326,821 | 3,433 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $337,970 | 3,427 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $368,705 | 3,463 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $312,973 | 3,437 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $411,245 | 3,609 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $436,836 | 3,678 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,011,491 | 12,587 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,207,275 | 13,087 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,801,778 | 17,072 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $452,485 | 4,165 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $460,321 | 4,265 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $509,865 | 4,093 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $614,099 | 4,088 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $538,710 | 3,994 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $159,238 | 1,068 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $170,389 | 999 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $267,854 | 1,039 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $268,349 | 983 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $209,775 | 937 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $101,219 | 927 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $32,608 | 400 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,192 | 75 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||